Core interpretation
The findings point most strongly to
post-ERCP pancreatitis (PEP). The key clue is the character and timing of the pain: severe, constant epigastric pain that bores through to the back, appearing within hours after ERCP with sphincterotomy and stone removal. This is the classic presentation of pancreatic inflammation triggered by the procedure.
Pancreatitis is the most common complication of ERCP and typically presents with epigastric pain radiating to the back, often accompanied by tachycardia, within hours of the procedure. The patient’s heart rate of
108/min reflects the systemic inflammatory response, while the mild temperature of
37.4 °C is consistent with early inflammation rather than established infection.
Why the other options are less likely
The abdomen is described as tender but not rigid.
Watch out! A rigid abdomen would point more toward
duodenal perforation, which typically causes peritoneal irritation and guarding. The absence of rigidity makes perforation less likely, although it cannot be completely excluded without imaging.
Bleeding at the sphincterotomy site would be suggested by a falling hemoglobin, melena, hematemesis, or hemodynamic instability. Here the hemoglobin is unchanged from before the procedure, and the blood pressure remains stable at
110/68 mmHg.
Key point! A stable hemoglobin and stable blood pressure argue against significant bleeding.
Recurrent infection behind a retained stone would be expected to produce returning fever with chills and jaundice. This patient’s temperature is only mildly elevated, and the dominant symptom is pain rather than a septic or obstructive biliary picture. The pain pattern—boring through to the back—is more pancreatic than biliary.
Pathophysiology of post-ERCP pancreatitis
During ERCP, instrumentation of the papilla and common bile duct can cause mechanical trauma, edema, or transient obstruction of the pancreatic duct. Sphincterotomy and stone manipulation increase the risk because they involve direct contact with the ampullary region and can impair pancreatic outflow. The resulting ductal hypertension and premature intracellular activation of pancreatic enzymes lead to autodigestion and inflammation of the pancreas.
The pain of pancreatitis is typically epigastric and constant, with radiation to the back, reflecting the retroperitoneal location of the pancreas and the inflammatory involvement of surrounding nerve plexuses.
Epidemiology and risk context
The reported incidence of PEP varies. One review describes a rate of
2–10% in general ERCP populations, rising to
30–50% in high-risk cases
[1]. Guidelines consistently identify PEP as the most common adverse event of ERCP
[2][3][4]. This patient has several recognized risk factors: female sex, obesity, and a procedure involving sphincterotomy with stone removal. The presence of acute cholangitis prior to the procedure may also contribute to local inflammation and increased susceptibility.
Clinical differentiation at the bedside
| Complication | Key findings | This patient |
|---|
| Post-ERCP pancreatitis | Severe epigastric pain radiating to back, tachycardia, onset within hours, elevated lipase | Matches: boring epigastric pain to back, HR 108/min, 4 hours post-procedure |
| Duodenal perforation | Rigid abdomen, peritoneal signs, free air on imaging | Not matching: abdomen tender but not rigid |
| Sphincterotomy bleeding | Falling hemoglobin, melena, hematemesis, hypotension | Not matching: hemoglobin unchanged, BP stable |
| Retained stone with cholangitis | Returning fever with chills, jaundice, biliary-type pain | Not matching: only mild temperature elevation, pain is pancreatic-type |
Nursing priority and anticipated action
The nurse should report the pain immediately and anticipate a serum
lipase level. Lipase is more specific than amylase for pancreatic inflammation and is the preferred laboratory test when PEP is suspected.
Early recognition of PEP is critical because severe cases can progress to multi-organ failure, peripancreatic fluid collections, and death in up to 1% of cases. [1] Supportive care includes intravenous fluids, analgesia, bowel rest, and close monitoring of hemodynamic status and urine output. Rectal NSAIDs such as indomethacin have been studied for prevention, but once PEP is established, management is primarily supportive
[4].
References (research sources)
- [1]
Post-ERCP Pancreatitis: Prevention, Diagnosis and Management.Research articleCahyadi O, Tehami N, de-Madaria E, Siau K (2022) · DOI: 10.3390/medicina58091261
- [2]
Clinical Practice Guidelines for post-ERCP pancreatitis 2023.GuidelineMukai S, Takeyama Y, Itoi T, Ikeura T, Irisawa A, Iwasaki E (2025) · DOI: 10.1111/den.15004
- [3]
Post-ERCP pancreatitis.Research articleArata S, Takada T, Hirata K, Yoshida M, Mayumi T, Hirota M (2010) · DOI: 10.1007/s00534-009-0220-5
- [4]
Complications of ERCP.Research articleTalukdar R (2016) · DOI: 10.1016/j.bpg.2016.10.007